Parametric Portfolio Associates’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.85M	Sell	39,164 -20,650	-35%	-$1.75M	﹤0.01%	2226
2021 Q4	$7.07M	Sell	59,814 -21,717	-27%	-$2.72M	﹤0.01%	1629
2021 Q3	$10.9M	Buy	81,531 +15,659	+24%	+$2.37M	0.01%	1291
2021 Q2	$10.7M	Buy	65,872 +38,365	+139%	+$2.99M	0.01%	1337
2021 Q1	$2.21M	Buy	27,507 +6,500	+31%	+$436K	﹤0.01%	2719
2020 Q4	$1.14M	Buy	21,007 +3,438	+20%	+$125K	﹤0.01%	2975
2020 Q3	$349K	Buy	17,569 +693	+4%	+$14.4K	﹤0.01%	3427
2020 Q2	$355K	Sell	16,876 -1,924	-10%	-$32.7K	﹤0.01%	3403
2020 Q1	$230K	Sell	18,800 -29,881	-61%	-$403K	﹤0.01%	3492
2019 Q4	$714K	Buy	48,681 +35,418	+267%	+$493K	﹤0.01%	3223
2019 Q3	$177K	Buy	13,263 +543	+4%	+$8.66K	﹤0.01%	3736
2019 Q2	$208K	Sell	12,720 -2,953	-19%	-$46.4K	﹤0.01%	3732
2019 Q1	$268K	Buy	+15,673	New	+$234K	﹤0.01%	3596
2018 Q4	–	Sell	-14,466	Closed	-$414K	–	3940
2018 Q3	$414K	Buy	14,466 +2,359	+19%	+$68.6K	﹤0.01%	3503
2018 Q2	$331K	Buy	+12,107	New	+$293K	﹤0.01%	3518